Roberto Burioni
Overview
Explore the profile of Roberto Burioni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
1437
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bruzzesi E, Gandini F, Diotallevi S, Lolatto R, Cernuschi M, Candela C, et al.
Microorganisms
. 2025 Jan;
12(12.
PMID: 39770774
Men who have sex with men (MSM) and people with HIV are at increased risk of anal HPV infection and cancer. This study aimed to assess the prevalence of anal...
2.
Criscuolo E, Giuliani B, Castelli M, Cavallaro M, Sisti S, Burioni R, et al.
Front Immunol
. 2024 Dec;
15:1501200.
PMID: 39664381
Introduction: The ongoing emergence of SARS-CoV-2 variants poses significant challenges to existing therapeutics. The spike (S) glycoprotein is central to both viral entry and cell-to-cell transmission via syncytia formation, a...
3.
Brambilla R, Gili R, Vigna Taglianti F, Lenzi J, Ricco M, Burioni R, et al.
Vaccines (Basel)
. 2024 Nov;
12(11).
PMID: 39591148
Background: The aim of this study was to estimate the effectiveness of original and bivalent COVID-19 vaccines in reducing COVID-19-associated hospitalizations among the adult population of Turin, Italy. Methods: We...
4.
Raccagni A, Diotallevi S, Lolatto R, Bruzzesi E, Martearena Garcia M, Mainardi I, et al.
Open Forum Infect Dis
. 2024 Nov;
11(11):ofae562.
PMID: 39498171
Background: 4CMenB appears to be effective in reducing (Ng) infections. Aims are to assess factors associated with breakthrough rectal Ng after 4CMenB and evaluate clinical and microbiological characteristics of breakthrough...
5.
Chandra P, Hazari S, Poat B, Gunduz F, Prabhu R, Liu G, et al.
Virol J
. 2024 Nov;
21(1):274.
PMID: 39487495
No abstract available.
6.
Raccagni A, Siribelli A, Diotallevi S, Sampaolo M, Bruzzesi E, Clementi N, et al.
Sex Transm Dis
. 2024 Aug;
51(12):772-774.
PMID: 39102506
This is a retrospective study on men who have sex with men (MSM) diagnosed with rectal lymphogranuloma venereum (LGV), treated with 7 or 21 days of doxycycline between 2015 and...
7.
Burioni R, Silvestrini L, DOrto B, Tete G, Nagni M, Polizzi E, et al.
Bioengineering (Basel)
. 2024 Apr;
11(4).
PMID: 38671808
Aim: The objective of this in vitro study was to compare reused and sterilized versus new healing abutments to assess whether a decontamination and sterilization process performed on resued healing...
8.
Lucente M, Raccagni A, Galli L, Lolatto R, Ranzenigo M, Ripa M, et al.
Sex Transm Dis
. 2024 Apr;
51(8):540-544.
PMID: 38647240
Background: Neisseria gonorrhoeae (Ng) is a public health priority because of the rapid evolution of antimicrobial resistance, the emergence of antibiotic resistance, and the absence of a vaccine against Ng....
9.
Gili R, Burioni R
J Transl Med
. 2023 Apr;
21(1):251.
PMID: 37038133
For the first time in the history of medicine, it has been possible to describe-after a spillover-the evolution of a new human virus spreading in a non-immune population. This allowed...
10.
Chen Y, Wang F, Yin L, Jiang H, Lu X, Bi Y, et al.
Nat Commun
. 2022 Dec;
13(1):7603.
PMID: 36494358
Influenza infection continues are a persistent threat to public health. The identification and characterization of human broadly neutralizing antibodies can facilitate the development of antibody drugs and the design of...